Effects of G-CSF and antibiotic prophylaxis in a 2×2 factorial design on outcome in septic rats

[1]  C. Edmiston,et al.  Fecal peritonitis: Microbial adherence to serosal mesothelium and resistance to peritoneal lavage , 1990, World Journal of Surgery.

[2]  C. Coopersmith,et al.  Antibiotics Improve Survival in Sepsis Independent of Injury Severity but do not Change Mortality in Mice with Markedly Elevated Interleukin 6 Levels , 2004, Shock.

[3]  F. Bozza,et al.  Antibiotic treatment in a murine model of sepsis: impact on cytokines and endotoxin release. , 2004, Shock.

[4]  N. Takeyama,et al.  Activation of neutrophil function by recombinant human granulocyte colony-stimulating factor improves the survival of rats with peritonitis , 1996, Surgery Today.

[5]  D. Sessler,et al.  Deleterious Effects of Mild Hypothermia in Septic Rats Are Ameliorated by Granulocyte Colony-stimulating Factor , 2003, Anesthesiology.

[6]  D. Öğünç,et al.  The Effect of Granulocyte Colony-Stimulating Factor in the Treatment of Escherichia coli Peritonitis With or Without Ceftriaxone in a Nonneutropenic Rat Model , 2003, Surgery Today.

[7]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[8]  M. Rothmund,et al.  Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patients with colorectal cancer and increased preoperative risk (ASA 3 and 4)¶ Protocol for a controlled clinical trial developed by consensus of an internati , 2001, Inflammation Research.

[9]  A. Tres,et al.  Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: a multicenter randomized trial. , 2001, Journal of the National Cancer Institute.

[10]  J. Armitage,et al.  A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation. , 2000, Blood.

[11]  H. Sitter,et al.  Influence of histamine H1 + H2 receptor antagonists on abdominal infections following minimally invasive versus conventional surgery: Studies in large samples of rats following the new concept of clinic modelling randomised trials (CMRT) , 1999, Inflammation Research.

[12]  T. Hasegawa,et al.  Granulocyte Colony-Stimulating Factor Enhances Endotoxin-Induced Decrease in Biliary Excretion of the Antibiotic Cefoperazone in Rats , 1998, Antimicrobial Agents and Chemotherapy.

[13]  E. Chantelau,et al.  Granulocyte-colonystimulating factor in diabetic foot infection , 1998, The Lancet.

[14]  S. Lenhoff,et al.  Effects of immunosuppressive drugs and antibiotics on GM‐CSF and G‐CSF secretion in vitro by monocytes, T lymphocytes and endothelial cells , 1996, British journal of haematology.

[15]  A. Roberts,et al.  Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. , 1995, Blood.

[16]  P. Wernet,et al.  Enhancement of neutrophil function by in vivo filgrastim treatment for prophylaxis of sepsis in surgical intensive care patients. , 1995, Journal of critical care.

[17]  H. Sitter,et al.  Granulocyte colony-stimulating factor prophylaxis before operation protects against lethal consequences of postoperative peritonitis. , 1994, Surgery.

[18]  S. Nelson.  Role of granulocyte colony-stimulating factor in the immune response to acute bacterial infection in the nonneutropenic host: an overview. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  T. Hartung,et al.  Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha. , 1992, Journal of immunology.

[20]  H. Tanaka,et al.  Pharmacokinetics of recombinant human granulocyte colony-stimulating factor in the rat. Single and multiple dosing studies. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[21]  I. Chaudry,et al.  Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. , 1983, Surgery.

[22]  D. DeMets,et al.  Fundamentals of Clinical Trials , 1982 .